The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 19, 2016

Filed:

Nov. 15, 2010
Applicants:

Zheng Xin Dong, Holliston, MA (US);

Jundong Zhang, Newton, MA (US);

Inventors:

Zheng Xin Dong, Holliston, MA (US);

Jundong Zhang, Newton, MA (US);

Assignee:

Ipsen Pharma S.A.S., Boulogne-Billancourt, FR;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/12 (2006.01); A61P 5/00 (2006.01); A61K 38/33 (2006.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61K 38/34 (2006.01); C07K 14/68 (2006.01); C07K 14/69 (2006.01);
U.S. Cl.
CPC ...
A61K 38/33 (2013.01); A61K 9/0019 (2013.01); A61K 9/08 (2013.01); A61K 38/34 (2013.01); C07K 14/68 (2013.01); C07K 14/69 (2013.01); A61K 9/0024 (2013.01);
Abstract

The present invention relates to improvements in compositions containing peptides that are ligands of one or more of the melanocortin receptors (MC-R), or pharmaceutically acceptable salts thereof, methods for preparing such compositions, and method of using such compositions to treat mammals. In particular, the present invention relates to a pharmaceutical composition comprising a pamoate salt of Ac-Arg-cyclo(Cys-D-Ala-His-D-Phe-Arg-Trp-Cys)-NHwhich is a ligand of the melanocortin receptor subtype 4 (MC4-R), and in which, after subcutaneous or intramuscular administration to a subject, the peptide forms a depot at physiological pH that is slowly dissolved and released into the body fluid and bloodstream. The present invention may further comprise an organic component such as dimethylacetamide (DMA) or polyethylene glycol (PEG) with an average molecular weight of lower than 1000.


Find Patent Forward Citations

Loading…